胸部病変位置同定法の世界市場予測(~2025年)

MarketsandMarketsが発行した調査報告書(MD 4236)
◆英語タイトル:Breast Lesion Localization Methods Market by Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2024
◆商品コード:MD 4236
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2019年5月16日
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

胸部病変位置同定法の世界市場は、2018年の4億1300万米ドルから2024年には5億9,800万米ドルに達し、この期間中6.3%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、乳がんの発生率の増加、乳がんの手術数の増加、および乳がん早期発見に関する意識の高まりが考えられます。一方で、規制当局による承認手続の不確実性は市場の成長を抑制すると予測されています。当調査レポートでは、胸部病変位置同定法の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類(ワイヤー、ラジオアイソトープ、磁気)別分析、使用法(腫瘍の識別、センチネルリンパ節)別分析、エンドユーザー選好調査(選択基準、代替動向)別分析、胸部病変位置同定法の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・胸部病変位置同定法の世界市場:市場インサイト
・胸部病変位置同定法の世界市場:市場概観/市場動向
・胸部病変位置同定法の世界市場:種類(ワイヤー、ラジオアイソトープ、磁気)別分析/市場規模
・胸部病変位置同定法の世界市場:使用法(腫瘍の識別、センチネルリンパ節)別分析/市場規模
・胸部病変位置同定法の世界市場:エンドユーザー選好調査(選択基準、代替動向)別分析/市場規模
・胸部病変位置同定法のアジア市場規模予測
・胸部病変位置同定法のヨーロッパ市場規模予測
・胸部病変位置同定法のアメリカ市場規模予測
・胸部病変位置同定法の世界市場動向
・胸部病変位置同定法の世界市場:競争状況
・胸部病変位置同定法の世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

“The increasing incidence of breast cancer and number of breast cancer surgeries are expected to drive the overall growth of the breast lesion localization methods market.”The breast lesion localization methods market is expected to grow from USD 413 million in 2018 to USD 598 million by 2024, at a CAGR of 6.3% during the forecast period. The breast lesion localization methods market is driven primarily by the increasing incidence of breast cancer, rising number of breast cancer surgeries, and growing awareness on the early detection of breast cancer. However, uncertainty in regulatory approval procedures is expected to restrain the growth of this market during the forecast period.
“The wire localization segment held the largest share of the breast lesion localization methods market in 2018.”
Based on type, the breast lesion localization methods market is divided into five major segments—wire localization, isotope localization, magnetic localization, electromagnetic localization, and others. The wire localization segment accounted for the largest share of the breast lesion localization methods market in 2018. The large share of this segment is attributed to its accuracy in abnormal tissue localization, minimum removal of normal tissues, minimal scarring, and the availability of reimbursement for breast lesion localization devices.
“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
The Asia Pacific is projected to record the highest growth in the breast lesion localization methods market during the forecast period. The rapidly increasing patient population, increasing healthcare expenditure, improving healthcare infrastructure, high government spending on breast cancer research, and increasing awareness are the major factors supporting the growth of the Asia Pacific breast lesion localization methods market.
The report also contains a detailed analysis of end-user preference for the adoption of different breast lesion localization methods. The research findings cited in the report encapsulates the important selection criteria for breast lesion localization methods from an end-user point of view. It analyses importance given to the particular criteria while selecting a breast lesion localization methods. Important criteria for the selection of breast lesion localization methods include detection and success rate, re-excision rate, cost, mean localization time, effectiveness, safety, and ease of use.
In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the breast lesion localization method market.
By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
By Region: North America: 48%, Europe: 24%, APAC: 19%, and the RoW: 9%

Some of the key players in the breast lesion localization methods market are C.R. Bard (US), Ranfac Corporation (US), SOMATEX Medical Technologies GmbH (Germany), Argon Medical Devices (US), SurgicEye GmbH (Germany), Intra-Medical Imaging LLC (US), IsoAid, LLC (US), Cianna Medical (US), Endomagnetics Ltd. (UK), and Cook Medical (US). The study includes an in-depth competitive analysis of these key players in the breast lesion localization methods market, along with their company profiles, recent developments, and key market strategies.
Research Coverage:
The market study covers the breast lesion localization methods market across various segments. It aims at estimating the market size (in terms of volume) and the growth potential of this market across different segments by type, usage, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of breast lesion localization procedures market and its subsegments. This report will help stakeholders to understand the competitive landscape, gain insights to better position their businesses, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DESIGN
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 MARKET SIZE ESTIMATION
2.4 PRIMARY RESEARCH (INTERVIEWS) – SAMPLING FRAME
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 RISING INCIDENCE OF BREAST CANCER
4.2.1.2 INCREASING NUMBER OF BREAST CANCER SURGERIES
4.2.1.3 INCREASING AWARENESS ON THE EARLY DETECTION OF BREAST
CANCER
4.2.2 RESTRAINTS
4.2.2.1 UNCERTAINTY IN REGULATORY APPROVAL PROCEDURES
4.2.2.2 VISIONARY LEADERS
4.2.3 OPPORTUNITIES
4.2.3.1 INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED
ELECTROMAGNETIC REFLECTORS
4.2.3.1 DEARTH OF ONCOLOGISTS
4.2.4 CHALLENGES
4.2.4.1 DEARTH OF ONCOLOGISTS

5 BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, MILLION PROCEDURES/USD MILLION (2016-2024)
5.1 INTRODUCTION
5.2 WIRE LOCALIZATION
5.3 RADIOISOTOPE LOCALIZATION
5.3.1 RADIOGUIDED OCCULT LESION LOCALIZATION
5.3.2 RADIOACTIVE SEED LOCALIZATION
5.4 ELECTROMAGNETIC LOCALIZATION
5.5 MAGNETIC LOCALIZATION
5.6 OTHER LOCALIZATION METHODS
6 BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, MILLION PROCEDURES
(2016-2024)
6.1 INTRODUCTION
6.2 TUMOR IDENTIFICATION
6.3 SENTINEL LYMPH NODE IDENTIFICATION
6.3.1 LUMPECTOMY
6.3.2 MASTECTOMY
7 BREAST LESION LOCALIZATION METHODS MARKET, BY REGION, MILLION PROCEDURES
(2016-2024)
7.1 INTRODUCTION
7.2 ASIA PACIFIC
7.3 EUROPE
7.4 NORTH AMERICA
7.4.1 US
7.4.2 CANADA
7.5 REST OF THE WORLD
8 COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPETITIVE LEADERSHIP MAPPING
8.2.1 STRENGTH OF PRODUCT PORTFOLIO
8.2.2 BUSINESS STRATEGY EXCELLENCE
8.3 COMPETITIVE SCENARIO
8.4 END USER PREFERENCE STUDY
8.4.1 BREAST LESION LOCALIZATION METHODS: COMPARATIVE ANALYSIS
8.4.2 BREAST LESION LOCALIZATION METHODS: SELECTION CRITERIA EVALUATION
8.4.3 QUALITATIVE ASSESSMENT OF REPLACEMENT TREND


9 COMPANY PROFILE
9.1 OVERVIEW ARGON MEDICAL DEVICES
9.1.1 BUSINESS OVERVIEW
9.1.2 PRODUCT OFFERED
9.2 B.D. COMPANY
9.2.1 BUSINESS OVERVIEW
9.2.2 BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
9.2.3 PRODUCT OFFERED
9.2.4 RECENT DEVELOPMENTS
9.3 CIANNA MEDICAL
9.3.1 BUSINESS OVERVIEW
9.3.2 MERIT MEDICAL SYSTEMS, INC: COMPANY SNAPSHOT (2018)
9.3.3 PRODUCT OFFERED
9.3.4 RECENT DEVELOPMENTS
9.4 COOK MEDICAL
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCT OFFERED
9.5 ENDOMAGNETICS LTD
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCT OFFERED
9.5.3 RECENT DEVELOPMENTS
9.6 HEALTH BEACON
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCT OFFERED
9.6.3 RECENT DEVELOPMENTS
9.7 INTRA-MEDICAL IMAGING LLC
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCT OFFERED
9.8 ISOAID, LLC
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCT OFFERED
9.9 LEICA BIOSYSTEMS
9.9.1 BUSINESS OVERVIEW
9.9.2 DANAHER: COMPANY SNAPSHOT (2018)
9.9.3 BUSINESS OVERVIEW
9.9.4 RECENT DEVELOPMENTS
9.10 SOMATEX MEDICAL TECHNOLOGIES GMBH
9.10.1 BUSINESS OVERVIEW
9.10.2 PRODUCT OFFERED
9.10.3 RECENT DEVELOPMENTS

9.11 SURGICEYE GMBH
9.11.1 BUSINESS OVERVIEW
9.11.2 PRODUCT OFFERED
9.12 RANFAC CORPORATION
9.12.1 BUSINESS OVERVIEW
9.12.2 PRODUCT OFFERED
10 APPENDIX
10.1 DISCUSSION GUIDE
10.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
10.4 AVAILABLE CUSTOMIZATIONS
10.5 RELATED REPORTS
10.6 AUTHORS DETAILS

LIST OF TABLES

TABLE 1 BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2016–2024 (MILLION PROCEDURES)
TABLE 2 BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2016–2024 (USD MILLION)
TABLE 3 WIRE LOCALIZATION METHODS MARKET, BY REGION,
2016–2024 (MILLION PROCEDURES)
TABLE 4 NORTH AMERICA: WIRE LOCALIZATION METHODS MARKET, BY COUNTRY,
2016–2024 (MILLION PROCEDURES)
TABLE 5 WIRE LOCALIZATION MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 6 NORTH AMERICA: WIRE LOCALIZATION MARKET, BY COUNTRY,
2016–2024 (USD MILLION)
TABLE 7 RADIOISOTOPE LOCALIZATION METHODS MARKET, BY REGION,
2016–2024 (MILLION PROCEDURES)
TABLE 8 NORTH AMERICA: RADIOISOTOPE LOCALIZATION METHODS MARKET,
BY COUNTRY, 2016–2024 (MILLION PROCEDURES)
TABLE 9 RADIOISOTOPE LOCALIZATION MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 10 NORTH AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY COUNTRY,
2016–2024 (USD MILLION)
TABLE 11 RADIOISOTOPE LOCALIZATION MARKET, BY PRODUCT,
2016–2024 (MILLION PROCEDURES)
TABLE 12 RADIOISOTOPE LOCALIZATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 13 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY REGION,
2016–2024 (MILLION PROCEDURES)
TABLE 14 NORTH AMERICA: RADIOGUIDED OCCULT LESION LOCALIZATION MARKET,
BY COUNTRY, 2016–2024 (MILLION PROCEDURES)
TABLE 15 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY REGION,
2016–2024 (USD MILLION)
TABLE 16 NORTH AMERICA: RADIOGUIDED OCCULT LESION LOCALIZATION MARKET,
BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 17 RADIOACTIVE SEED LOCALIZATION MARKET, BY REGION,
2016–2024 (MILLION PROCEDURES)
TABLE 18 NORTH AMERICA: RADIOACTIVE SEED LOCALIZATION MARKET, BY COUNTRY,
2016–2024 (MILLION PROCEDURES)
TABLE 19 RADIOACTIVE SEED LOCALIZATION MARKET, BY REGION,
2016–2024 (USD MILLION)
TABLE 20 NORTH AMERICA: RADIOACTIVE SEED LOCALIZATION MARKET,
BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 21 ELECTROMAGNETIC LOCALIZATION METHODS MARKET, BY REGION,
2016–2024 (MILLION PROCEDURES)
TABLE 22 ELECTROMAGNETIC LOCALIZATION METHODS MARKET, BY REGION,
2016–2024 (USD MILLION)
TABLE 23 MAGNETIC LOCALIZATION METHODS MARKET, BY REGION,
2016–2024 (MILLION PROCEDURES)
TABLE 24 NORTH AMERICA: MAGNETIC LOCALIZATION METHODS MARKET, BY COUNTRY,
2016–2024 (MILLION PROCEDURES)
TABLE 25 MAGNETIC LOCALIZATION METHODS MARKET, BY REGION,
2016–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: MAGNETIC LOCALIZATION METHODS MARKET, BY COUNTRY,
2016–2024 (USD MILLION)
TABLE 27 OTHER BREAST LESION LOCALIZATION METHODS MARKET, BY REGION,
2016–2024 (MILLION PROCEDURES)
TABLE 28 NORTH AMERICA: OTHER BREAST LESION LOCALIZATION METHODS MARKET,
BY COUNTRY, 2016–2024 (MILLION PROCEDURES)
TABLE 29 OTHER BREAST LESION LOCALIZATION METHODS MARKET, BY REGION,
2016–2024 (USD MILLION)
TABLE 30 NORTH AMERICA: OTHER BREAST LESION LOCALIZATION METHODS MARKET,
BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 31 BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2016–2024 (MILLION PROCEDURES)
TABLE 32 BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE
IDENTIFICATION, BY SURGERY TYPE, 2016–2024 (MILLION PROCEDURES)
TABLE 33 BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE
IDENTIFICATION, BY REGION, 2016–2024 (MILLION PROCEDURES)
TABLE 34 BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE
IDENTIFICATION, BY COUNTRY, 2016–2024 (MILLION PROCEDURES)
TABLE 35 SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR LUMPECTOMY, BY REGION,
2016–2024 (MILLION PROCEDURES)
TABLE 36 NORTH AMERICA: SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR
LUMPECTOMY, BY COUNTRY, 2016–2024 (MILLION PROCEDURES)
TABLE 37 GLOBAL NUMBER OF MASTECTOMY PROCEDURES PER 10,000 POPULATION,
2012–2024
TABLE 38 SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR MASTECTOMY, BY REGION,
2016–2024 (MILLION PROCEDURES)
TABLE 39 NORTH AMERICA: SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR
MASTECTOMY, BY COUNTRY, 2016–2024 (MILLION PROCEDURES)
TABLE 40 BREAST LESION LOCALIZATION METHODS MARKET FOR TUMOR IDENTIFICATION,
BY REGION, 2016–2024 (MILLION PROCEDURES)
TABLE 41 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET FOR
TUMOR IDENTIFICATION, BY COUNTRY, 2016–2024 (MILLION PROCEDURES)
TABLE 42 BREAST LESION LOCALIZATION METHODS MARKET, BY REGION,
2016–2024 (MILLION PROCEDURES)
TABLE 43 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2016–2024 (MILLION PROCEDURES)
TABLE 44 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION MARKET, BY PRODUCT,
2016–2024 (MILLION PROCEDURES)
TABLE 45 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2016–2024 (MILLION PROCEDURES)
TABLE 46 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET FOR
SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE,
2016–2024 (MILLION PROCEDURES)
TABLE 47 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2016–2024 (MILLION PROCEDURES)
TABLE 48 EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY PRODUCT,
2016–2024 (MILLION PROCEDURES)
TABLE 49 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2016–2024 (MILLION PROCEDURES)
TABLE 50 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2016–2024 (MILLION PROCEDURES)
TABLE 51 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2016–2024 (MILLION PROCEDURES)
TABLE 52 NORTH AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY PRODUCT,
2016–2024 (MILLION PROCEDURES)
TABLE 53 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2016–2024 (MILLION PROCEDURES)
TABLE 54 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE,
2016–2024(MILLION PROCEDURES)
TABLE 55 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET,
BY COUNTRY, 2016–2024 (MILLION PROCEDURES)
TABLE 56 US: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2016–2024 (MILLION PROCEDURES)
TABLE 57 US: RADIOISOTOPE LOCALIZATION MARKET, BY PRODUCT,
2016–2024 (MILLION PROCEDURES)
TABLE 58 US: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2016–2024 (MILLION PROCEDURES)
TABLE 59 US: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2016–2024 (MILLION PROCEDURES)
TABLE 60 CANADA: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2016–2024 (MILLION PROCEDURES)
TABLE 61 CANADA: RADIOISOTOPE LOCALIZATION MARKET, BY PRODUCT,
2016–2024 (MILLION PROCEDURES)
TABLE 62 CANADA: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2016–2024 (MILLION PROCEDURES)
TABLE 63 CANADA: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2016–2024 (MILLION PROCEDURES)
TABLE 64 ROW: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2016–2024 (MILLION PROCEDURES)

TABLE 65 ROW: RADIOISOTOPE LOCALIZATION MARKET, BY PRODUCT,
2016–2024 (MILLION PROCEDURES)
TABLE 66 ROW: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2016–2024 (MILLION PROCEDURES)
TABLE 67 ROW: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2016–2024 (MILLION PROCEDURES)


LIST OF FIGURES

FIGURE 1 BREAST LESION LOCALITION METHODS MARKET, BY TYPE (MILLION PROCEDURES)
FIGURE 2 RADIOISOTOPES LOCALIZATION MARKET, BY PRODUCT (MILLION PROCEDURES)
FIGURE 3 BREAST LESION LOCALITION METHODS MARKET, BY USGAE (MILLION PROCEDURES)
FIGURE 4 SENTINEL LYMPH NODE IDENTIFICATION MARKET, BY SURGERY TYPE
(MILLION PROCEDURES)
FIGURE 5 BREAST LESION LOCALITION METHODS MARKET, BY REGION (MILLION PROCEDURES)
FIGURE 6 GLOBAL INCIDENCE OF BREAST CANCER, 2012–2025
FIGURE 7 ESTIMATION OF BREAST CANCER SURGERIES (US & OUTSIDE US), 2012–2024
FIGURE 8 REIMBURSEMENT FOR BREAST LESION LOCALIZATION DEVICE PLACEMENT,
2014–2018
FIGURE 9 BREAST LESION LOCALIZATION METHODS MARKET (GLOBAL),
COMPETITIVE LEADERSHIP MAPPING, 2018


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 胸部病変位置同定法の世界市場予測(~2025年)(Breast Lesion Localization Methods Market by Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆